Running on the China Bridge to Innovation 2019

Running on the China Bridge to Innovation 2019


What are the latest trends shaping the biopharma industry in China? Based on interviews with biopharma C-suite from China and the West, the exclusive Running on the China Bridge to Innovation by McKinsey & Company was commissioned for the 6th BioCentury-BayHelix China Healthcare Summit (Nov. 18-20, 2019, Shanghai).

Return to Whitepapers

Topics Discussed

  • What are the key characteristics required for biopharma companies to achieve high growth in China?
  • What are the top tailwinds and headwinds in China for the next three years?
  • How much will China factor into global R&D strategies?
  • What are the top operational priorities for China biotech CEOs?
  • Plus: A deep dive into China’s oncology market

Download the Whitepaper

To download Running on the China Bridge to Innovation 2019, please click the DOWNLOAD link below.